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ABSTRACT
Proper endosomal trafficking of ligand-activated G-protein-coupled
receptors (GPCRs) is essential to spatiotemporally tune their
physiological responses. For the monocyte chemoattractant
receptor 2 (CCR2B; one of two isoforms encoded by CCR2),
endocytic recycling is important to sustain monocyte migration,
whereas filamin A (FLNa) is essential for CCL2-induced monocyte
migration. Here, we analyze the role of FLNa in the trafficking of
CCR2B along the endocytic pathway. In FLNa-knockdown cells,
activated CCR2B accumulated in enlarged EEA-1-positive
endosomes, which exhibited slow movement and fast fluorescence
recovery, suggesting an imbalance between receptor entry and exit
rates. Utilizing super-resolution microscopy, we observed that FLNa–
GFP, CCR2B and β2-adrenergic receptor (β2AR) were present in
actin-enriched endosomal microdomains. Depletion of FLNa
decreased CCR2B association with these microdomains and
concomitantly delayed CCR2B endosomal traffic, without
apparently affecting the number of microdomains. Interestingly,
CCR2B and β2AR signaling induced phosphorylation of FLNa at
residue S2152, and this phosphorylation event was contributes to
sustain receptor recycling. Thus, our data strongly suggest that
CCR2B and β2AR signals to FLNa to stimulate its endocytosis and
recycling to the plasma membrane.
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INTRODUCTION
A key aspect of the cellular responses mediated by G-protein-
coupled receptors (GPCRs) is the spatiotemporal regulation of their
signaling, which occurs at the level of ligand binding but also
through control of the number of receptors on the cell surface.
Therefore, explaining the control of receptor sorting into different
degradative or recycling endocytic pathways is fundamental to
understand GPCR function. Once internalized, receptors follow
different fates inside the cell: some rapidly return to the plasma
membrane from the sorting endosome, others travel to the
perinuclear endosomes for slower recycling or are transported to
lysosomes for degradation. Receptor sorting within endosome
trafficking is facilitated by dynamic actin filaments, which are
generated throughWASH and the Arp 2/3 complex at the surface of
endosomes (Derivery et al., 2009; Gomez and Billadeau, 2009) and
specialized protein interactions. Some GPCRs, such as β2-
adrenergic receptor (β2AR), have specific sequences that trap the
receptor in endosomal actin-enriched subdomains for transport
along the short recycling route – so called ‘sequence-dependent’
recycling (Cao et al., 1999; Puthenveedu et al., 2010). The
sequence-dependent pathways require PDZ-containing proteins
and the retromer complex (Temkin et al., 2011). In those routes,
the actin-enriched subdomains are thought to function as platforms
that capture cargo proteins into retromer tubules, retrieving them
from the default pathway.
The diversity of actin functions along the endocytic pathway is
the result of proteins that precisely control the architecture of the
actin networks and of the interacting partners among the endocytic
cargo and the endocytic machinery. Some of the most prominent
actin-cross-linking proteins in higher eukaryotes are the filamins
(filamin A, B and C; FLNa, FLNb and FLNc, respectively)
(Nakamura et al., 2011). FLNa is a dimeric protein with 24
immunoglobulin (Ig) repeats that cross-link rod-like actin filaments
at right angles, creating three-dimensional networks (Hartwig et al.,
1980). FLNa exists as an autoinhibitory form that involves Ig repeat
20 (Lad et al., 2007). In addition, FLNa binds to a myriad of cellular
proteins of great functional diversity, acting as a scaffold and
facilitating protein–protein interactions (Popowicz et al., 2006).
Thereby, FLNa integrates the cellular architecture and signaling
cascades that are essential for fetal development and cell
locomotion. Not surprisingly, mutations in FLNa are linked to a
large number of developmental diseases (Savoy and Ghosh, 2013).
Among its partners are several GPCRs (Awata et al., 2001; Kim
et al., 2005; Onoprishvili et al., 2003; Yu et al., 2008), including
several chemokine receptors: CCR2B (one of two alternative splice
forms encoded by CCR2) (Minsaas et al., 2010; Planagumà et al.,
2012), CCR5 and CXCR4 (Gómez-Moutón et al., 2015; Jiménez-
Baranda et al., 2007). The exact role of FLNa binding to chemokine
receptors is not well understood yet, but much work indicates its
function in endocytic traffic and receptor internalization (Cho et al.,
2007; Kim et al., 2005; Onoprishvili et al., 2003; Seck et al., 2003).
Moreover, FLNa binds to β-arrestin-2, a well-defined GPCR
adaptor for clathrin-mediated internalization (Kim et al., 2005;
Scott et al., 2006). Recently, FLNa has been suggested to cooperate
with binding of β-arrestin-2 to the CXCR4 receptor carrying
mutations in arginine residue 334 that are present in WHIM
syndrome, which could have implications in WHIM-mutant
CXCR4 signaling (Gómez-Moutón et al., 2015).
We have previously shown that FLNa, through predominantly Ig
repeats 19–23, binds to the C-terminal tail of the monocyte
chemoattractant receptor 2 (CCR2, isoform B) (Minsaas et al.,
2010). CCR2 and its ligand, the monocyte chemoattractant protein 1Received 15 June 2016; Accepted 18 November 2016
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(CCL2), are involved in a wide variety of pathophysiological
inflammatory processes (Deshmane et al., 2009; Johnson et al.,
2005; Sallusto and Baggiolini, 2008) and neurodegenerative
disorders (Bose and Cho, 2013). Similar to most ligand-bound
GPCRs, CCL2-stimulated CCR2 is internalized in clathrin-coated
vesicles (García Lopez et al., 2009), which is important to regulate
its cellular signaling response (García Lopez et al., 2009; Jiménez-
Sainz et al., 2003). The interaction of FLNa with the C-terminal
region of CCR2B is essential for receptor internalization in
endocytic vesicles and for CCL2-induced monocyte migration
(Minsaas et al., 2010; Planagumà et al., 2012). Here, we show that
FLNa contributes to CCR2B recycling by controlling the motility of
endosomes and the entrance of the receptor into the endosomal actin
microdomains that recruit cargo destined for the short-loop
recycling pathway. We further show that CCL2-induced
phosphorylation of FLNa at S2152 is required to facilitate
receptor recycling, suggesting that GPCRs can control the
membrane-traffic machinery and spatiotemporally tune its
signaling. We have also demonstrated that this mechanism is
shared by other GPCRs.
RESULTS
CCR2B accumulates in enlarged early endosomes
in FLNa-depleted cells
CCR2B directly interacts with the Rod 1 domain of FLNa, within Ig
repeat 19, through the C-terminal intracellular domain of the
receptor. This interaction facilitates internalization of the ligand-
activated receptor into clathrin-coated pits (Minsaas et al., 2010).
We noticed that endosomal structures containing CCR2B appeared
to be more peripherally distributed upon ligand stimulation in the
human melanoma cell line M2 (lacking expression of FLNa)
compared with the isogenic cell line (Minsaas et al., 2010). Initial
experiments published previously had also indicated a defect in
receptor recycling upon FLNa depletion (Minsaas et al., 2010). This
suggests that FLNa plays roles in CCR2B endosomal trafficking,
other than those previously reported. To analyze the role of FLNa in
CCR2B trafficking through the endocytic pathway, the
internalization of Flag–CCR2B was followed with live confocal
microscopy in HeLa cells that had been depleted of FLNa by
utilizing short hairpin (sh)RNAs (Fig. 1A; Fig. S1A). The results
were consistent with previous data and showed CCR2B in
peripheral endosomal structures in the absence of FLNa, 30 min
after addition of CCL2 (Fig. S1B). Close observation of receptor-
loaded endosomes by live confocal imaging revealed an apparent
enlargement of the CCR2B-loaded organelles in cells that had been
treated with two different shRNAs against FLNa (shFLNa28 and
shFLNa29) (Fig. 1A; Fig. S1B). Morphometric analysis showed a
significant 1.4-fold increase in the diameter of the CCR2B-loaded
endosomes (P<0.001, one way ANOVA) in the absence of FLNa
(Fig. 1B).
To study the nature of the enlarged endosomal particles, HeLa
cells that expressed CCR2B were stimulated with CCL2 at different
times, fixed and co-labeled with antibodies against Flag and EEA-1
(Fig. 1C; see Fig. S1C for lower magnification). Some internalized
CCR2B particles colocalized with EEA-1 in the presence or absence
of FLNa 15 min after CCL2 addition, but the localization of
internalized CCR2B with EEA1 became more apparent in shFLNa
(shFLNa28)- than in control (shScr)-treated cells at later time points
(30 min) (Fig. 1C). This suggests that, although the arrival and exit
rates of CCR2B from EEA1-positive endosomes reached the
steady-state 15 min after addition of CCL2 in control cells, CCR2B
continued to accumulate in the absence of FLNa over at least 15
more minutes. Quantification of fluorescence indicated that
knockdown of FLNa expression increased the colocalization of
CCR2B with EEA-1 endosomes 1.6-fold (P<0.05, two way
ANOVA) at 30 min, compared to controls (Fig. 1D). This implied
that, in the absence of FLNa, the EEA-1-labeled endosomes kept
their capacity to receive incoming vesicles from the plasma
membrane for at least 30 min after addition of CCL2 and that the
exit of CCR2 from early endosomes was delayed.
FLNa contributes to early endosomal motility
As the receptor accumulates in enlarged early endosomes in the
absence of FLNa, we studied the effect of FLNa depletion on the
dynamic behavior of CCR2B-loaded endosomes using high-speed
[20 frames per second (fps)] imaging. Analysis of immunolabeled
CCR2B-positive endosome trajectories that lasted more than 1 min
showed a reduction in endosomal velocity [25±5% (mean±s.e.m.)
slower than that of controls] and distance traveled [30±5.5%
(mean±s.e.m.) shorter than that in controls] in shFLNa cells
(Fig. 2A). Significant differences were observed within 15 and
30 min after addition of CCL2, which were independent of the size
of the endocytic structures. These experiments allowed us to
observe long-range endosome trajectories directed towards the
perinuclear region in control cells, whereas in shFLNa cells,
CCR2B endosomes moved in random directions with their
trajectories remaining close to the origin (Fig. 2B).
To analyze the balance between CCR2B entry and exit rates in
and out of sorting endosomes, fluorescent resonance after photo-
bleaching (FRAP) experiments were conducted in living cells
expressing Rab4A–YFP, loaded with Alexa-Fluor-647-conjugated
antibodies against CCR2B. Endosomes with similar levels of
CCR2B–Alexa-Fluor-647 fluorescence and size were selected, and
one whole endosome was bleached in its entirety. After FRAP, only
11±1.3% (mean±s.e.m.) of the receptor signal on Rab4A-
containing endosomes was recovered after 2.5 min in control cells
(Fig. 2C, upper panels; Movie 1). The recovery of the CCR2B signal
was faster in the shFLNa cells [18±1.8% (mean±s.e.m.) after
2.5 min (Fig. 2D), compared to controls and to bleached Rab4A–
YFP, which showed no differences (Fig. S2; Movie 2). This was
despite FLNa depletion hindering the internalization of CCR2B and
the motility of the primary endocytic vesicles. Taken together,
the data strongly suggest that the exit of CCR2B from sorting
endosomes was impaired in the absence of FLNa.
FLNa facilitates CCR2B and β2AR loading in actin rich
subdomains
To study which route CCR2B follows back to the plasma
membrane, we analyzed the extent of its colocalization with
Rab4A and compared it with that of other well-known receptors
[transferrin (Tfn) receptor, β2AR, PAR1 (also known as F2R) and
ETB (also known as EDNRB)] (Fig. 3A,B). CCL2-stimulated
CCR2B, as well as the other receptors, accumulated in
microdomains along the Rab4A-decorated endosome membrane.
Utilizing line fluorescence correlation (Fig. 3A,B), we found that
Tfn was present in most Rab4A-labeled microdomains; consistent
with previous reports showing the Tfn receptor can follow both the
short- and the long-loop recycling routes (Mayle et al., 2012). Other
GPCRs (PAR1 and Etb), which are sorted to lysosomes (Shapiro
and Coughlin, 1998; Terada et al., 2014), hardly correlated with
Rab4A microdomains (Fig. 3B; Fig. S3). In contrast, internalized
CCR2B coincided with about 20% of the Rab4A-enriched
microdomains, similar to β2AR, which mainly follows the short
recycling loop from the sorting endosome to the plasma membrane.
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In fact, CCR2B (Flag–CCR2B) and β2AR (HA–β2AR) often
colocalized or were found in close apposition on endosomal
microdomains and moved together along the endosomal membrane
(Fig. 3C,D), indicating that they follow the same trafficking
pathway. As previously described (Temkin et al., 2011), β2AR
microdomains were positive for coronin2–GFP, which marks the
actin-enriched structures that trap cargo destined for the short-loop
recycling pathway from sorting endosomes to the plasma membrane
(Fig. 3E, lower panel). Consistent with the view that CCR2B
followed the same route as coronin2, CCR2B-labeled
microdomains also localized with coronin2–GFP (Fig. 3E, see
also line profile).
To investigate if FLNa might be directly involved in the
endosomal trafficking of CCR2, super-resolution microscopy
(STED) was utilized to determine its presence on endosomes.
The fluorescence signal of a functional FLNa–GFP construct
(Planagumà et al., 2012) was most apparent at the cortex of HeLa
cells (Fig. 4A). However, taking a sagittal plane of the cell, FLNa–
GFP could be detected at discrete dynamic subdomains on the
surface of vacuolar structures (Fig. 4A, lower panel). Interestingly,
FLNa–DsRed colocalized with coronin2–GFP dots on the vacuolar
membranes, indicating that FLNa might directly participate in the
function and regulation of the actin-enriched microdomains in
trapping cargo for the retromer pathway to the plasma membrane
(Fig. 4B). To confirm so, we investigated whether some of these
FLNa–GFP microdomains coincided with internalized
fluorescence-labeled CCR2B. CCR2B was present in Rab4A–
Cherry-labeled sorting endosomes in accumulations, which
transiently coincided with FLNa–GFP microdomains (Fig. 4C,D;
seeMovies 3 and 4). The CCR2B- and FLNa-labeled accumulations
were very mobile (Fig. 4C). As anticipated, FLNa–GFP localized
with actin–RFP and CCR2B on receptor-loaded early endosomes
(Fig. 4D). It was also possible to observe FLNa together with
CCR2Bon domains inRab5A–Cherry-labeled endosomes (Fig. 4D;
Movie 4). However, little coincidence was observed in Rab11–
Cherry-labeled endosomes (Fig. 4D; Movie 5). These results
indicate that FLNa and CCR2B colocalized on the endosomal
actin and coronin2-enriched early endosomal microdomains, similar
to internalized HA– β2AR (Fig. 4E, see also Fig. 5).
We next asked if FLNa is important to maintain the actin-
enriched endosomal subdomains. Depletion of FLNa did not alter
either the number or the intensity of the coronin2–GFP patches on
the endosomes (Fig. 5A,B), suggesting that FLNa is not essential to
generate or maintain the structure of coronin2–actin patches on
endosomes. Strikingly though, we observed that depletion of FLNa
clearly decreased the association of fluorescence-labeled
Fig. 1. FLNa knockdown promotes accumulation of CCR2B at early endosomes. (A) Confocal micrographs of live HeLa cells that had been transfected with
shRNAs against FLNa (shFLNa28 and shFLNa29, also referred to as sh28 and sh29, respectively) or a scrambled control (shScr) and plated in glass chambers.
The cells also expressed Flag–CCR2B, were surface labeled with anti-Flag and Alexa-Fluor-488-conjugated anti-mouse antibodies. Images were captured
60 min after CCL2 addition in a sealed chamber under 5% CO2 at 37°C. See Fig. S1C for images with low magnification. (B) Box plots showing the endosome
diameter measured using the line tool of the software Las Af (Leica microsystems). Lines represent the median, and boxes show the 25th and 75th
percentiles of the endosome diameters in sh28, sh29 and shScr cells. Whiskers indicate s.d. A minimum of eight cells in three separate experiments were
quantified with 30 endosomes per cell, approximately. Data were analyzed using one way ANOVA test (***P<0.001). (C) Confocal micrographs of HeLa cells
expressing shFLNa28 and shScr along with CCR2B, were incubated with 20 nM CCL2 for 15 min at 37°C, fixed and immunostained with anti-EEA-1 antibodies
followed by Alexa-Fluor-488-conjugated and M1 anti-Flag antibodies, and then with an Alexa-Fluor-568-conjugated secondary antibody, washed and mounted
with ProLong. Magnified images corresponding to small boxes are shown in the insets. Scale bars: 10 μm. See Fig. S1C for awider-field image. (D) Quantification
of the EEA-1 that colocalized with CCR2B in cells treated as described in C, 15 and 30 min after addition of 20 nM CCL2. Significance was determined using one
way ANOVA testing of three independent experiments. A significant difference was not found between 15 and 30 min for each shRNA-treated cell line, and there
was a significant difference between shScr and shFLNa at each time point (*P<0.05). Imaging was performed with a Leica TCS SP5 using a 63×1.3 NA oil
immersion lens. Scale bars: 10 μm.
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CCR2B with coronin2 on Rab4A-positive endosomal membranes
(Fig. 5A,C). Likewise, depletion of FLNa also diminished β2AR-
receptor-loading in coronin2-positive domains (Fig. 5C). These
results suggest that FLNa might be required for efficient loading
of some GPCRs onto the actin-enriched sorting endosome
microdomains.
FLNa is required for efficient CCR2B and β2AR recycling
If FLNa contributes to the concentration of certain GPCRs into
domains for subsequent loading of transport intermediates from the
sorting endosomes to the plasma membrane, its absence should alter
receptor endocytic transport and recycling. We analyzed the
recycling kinetics of CCR2B and β2AR in FLNa-depleted cells
by using fluorescence microscopy to measure the return of the
internalized receptor back to plasma membrane. Consistent with our
hypothesis, knocking down FLNa produced a significant delay in
the kinetics of the retrograde trafficking of the receptors to the
plasma membrane (Fig. 6A,B). Meanwhile, transport of the Tfn
receptor through the short or long recycling routes was unaffected in
shFLNa cells (Fig. 6C,D), as shown previously (Mayor et al., 1993).
Internal Tfn was normalized for the time 0 after the first stripping.
The data strongly indicated that general membrane traffic from the
endosomes to the cell surface was unaffected in FLNa-depleted
cells, but rather that FLNa depletion specifically altered the
transport of certain cargo.
Our data strongly indicate that FLNa acts as a trafficking adaptor
rather than as a structural protein during endosomal trafficking to the
plasma membrane. To further investigate this matter, we next asked
whether the FLNa regulation of CCR2B recycling involved the
FLNa actin-binding domain (ABD), which forms the orthogonal
actin networks (Janmey et al., 1990). Strikingly and consistent with
our hypothesis, the mouse mutant construct FLNa-ABD–DsRed,
with the actin-binding domain deleted (Muriel et al., 2011), resulted
in a similar level of receptor recycling to that with wild-type mouse
FLNa (Fig. 6E; Fig. S3A). Confocal micrographs of mouse FLNa-
ABD–DsRed denoted a prominent cytoplasmic distribution of the
mutant, which hindered its visibility on vacuolar structures, which
nevertheless could still be observed in some cells (Fig. S3A). These
results suggest that the predominant actin cross-linking activity of
FLNa might not be an important function of the protein in CCR2B
recycling; however, we cannot completely rule out the possibility
that the second actin-binding domain of FLNa that has been
reported previously (Nakamura et al., 2007) is sufficient for receptor
recycling. These results agree with our previous observations that
FLNa does not affect actin–coronin2 patches but might facilitate
loading of certain receptors into these microdomains.
FLNa is phosphorylated at multiple sites by several protein
kinases (Nakamura et al., 2011). Among these, phosphorylation at
residue S2152 (Muriel et al., 2011; Tigges et al., 2003; Travis et al.,
2004) has a clear impact on FLNa function. To study whether FLNa
Fig. 2. The motility and fluorescence recovery of endosomes is affected in FLNa-knockdown cells. (A) The track speed (left) and track length (right)
of CCR2B-loaded endosomes in shFLNa and shScr HEK293 cells that had been transfected with Flag–CCR2B and surface labeled with anti-Flag and Alexa-
Fluor-568-conjugated secondary antibodies before stimulation, as in Fig. 1A, were measured with Imaris (Bitplane). Endosomes were tracked for 15 min (Early),
then 15 minmore (Late) after ligand stimulation. (B) Nine representative tracks of data in A (each is a different color), longer than 1 min, for endosomes loadedwith
fluorescently labeled CCR2B, for each type of cell (shScr and shFLNa), from two independent experiments. (C) Time series of fluorescencemicrographs showing
FRAP analysis of CCR2B in Rab4A–YFP-loaded endosomes in control (shScr) and shFLNa cells treated as described in A. The 488-nm line was used to follow
the Rab4A-positive endosome, and the 633-nm line was used for bleaching an area enclosing the entire endosome (4 µm2) and for monitoring of receptor
fluorescence recovery over 2.5 min. Images were recorded as 16-bit sequences with a pinhole of 246 µm, giving a z-slice of 2 µm. Images were acquired at
3-s intervals. Data sets where the endosomemoved in the z-planewere discarded. Analysis with a control region of interest (ROI) drawn at a certain distance away
from the bleached ROI indicated no significant bleaching while fluorescence recovery was monitored. See Fig. S2A for Rab4A–YFP FRAP control. (D) Graphs
showing themobile fraction of CCR2B (left) and Rab4A (right) quantified from 50 endosomes from different cells as described in C. n=4 independent experiments.
See alsoMovie 1. Data are means±s.e.m. (*P<0.05, **P<0.01; ***P<0.001; two-tailed t-test). Imaging was performed with a Leica TCS SP5 using a 63×1.3 NA oil
immersion lens.
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phosphorylation is required to sustain CCR2B recycling, we
analyzed the capacity of FLNa-S2152 mutants to revert receptor
recycling defects in FLNa-knockdown cells by using flow
cytometry to analyze shFLNa cells (Fig. 6E). Western blot
analysis demonstrated that all constructs and mutants (regardless
of whether they were tagged with GFP or DsRed) were expressed at
similar levels (Fig. 6E,F, upper panels). We observed that the
phosphorylation mimetic FLNa mutant, S2152E, supported
receptor recycling similar to wild-type FLNa. However, the non-
phosphorylatable FLNa-S2152A mutant only partially recovered
CCR2B recycling. Consistent with this, the phospho-mimetic
mutant (FLNa-S2152E–DsRed or FLNa-S2152E–GFP) was
present on endosomal membranes (Fig. 6F; Fig. S3A,B), whereas
the GFP- or DsRed-tagged FLNa-S1252A mutant could hardly be
detected on these organelles (Fig. 6F; Fig S3A,B). This was despite
the fact that both mutants were present at the cellular cortex
Fig. 3. CCR2B colocalized with β2AR in coronin2-enriched microdomains. (A) HEK293 cells that had been transiently transfected with Rab4A–YFP and
Flag–CCR2B, Flag–β2AR, Flag–V2R (see images Fig. S2B), Flag–EtB (see images Fig. S2B) or Flag–PAR1 (see images Fig. S2B) were pre-labeled with anti-
Flag and Alexa-Fluor-647-conjugated anti-mouse antibodies, and induced to internalize with addition of the corresponding ligands or Alexa-Fluor-647–Tfn-
receptor and were imaged. Zoomed images of individual endosomes are shown. Right, fluorescence intensity profiles of receptors together with that of Rab4A–
YFP. (B) Quantification of the Pearson correlation profiles obtained from a minimum of eight endosomes in at least three independent experiments from A. AR,
β2AR; Tf, transferrin. (C)Micrographs of endosomal structures of live HEK293 cells expressing Rab4–Cherry, Flag–CCR2B andHA–β2AR that had been surface-
labeled with anti-Flag and anti-HA antibodies, followed by anti-mouse Alexa-Fluor-488- and anti-rat Alexa-Fluor-647-conjugated antibodies. Cells were treated
with 20 nM CCL2 and 10 μM isoproterenol before acquisition of images as in Fig. 1A. Arrowheads show colocalization of HA–β2AR and CCR2B. (D) Time-lapse
series from a representative endosome with Flag–CCR2B and HA–β2AR from C. (E) Confocal images of live cells that expressed coronin2–GFP and Flag–
CCR2B (up) or HA–β2AR (down) in Rab4A–Cherry-HeLa transfected cells. The cells were pre-labeled with anti-Flag and anti-mouse Alexa-Fluor-647-conjugated
antibodies, or anti-HA and anti-rat Alexa-Fluor-647-conjugated antibodies. Cells were treated with 20 nM CCL2 or 10 μM isoproterenol before acquisition of
images as in Fig. 1A. Arrowheads show colocalization of receptors with coronin2. Scale bars: 5 μm. In the middle panel, fluorescence intensity profiles of CCR2B
together with coronin2-GFP are shown, as in A.
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(Fig S3B,C). This suggests that phosphorylation of FLNa at residue
S2152 regulates its localization on endosomal structures.
CCR2and β2ARsignaling inducesphosphorylation of FLNaat
S2152
We also investigated whether the activation of CCR2B could itself
induce FLNa phosphorylation as a mechanism to control its own
trafficking. For this, we utilized a specific antibody against FLNa
phosphorylated at S2152. The specificity of the antibody was
validated by immunoblot analysis of cells expressing the FLNa-
S2152A–GFP mutant in shFLNa-transfected HEK293 cells
(Fig. 7A). Only the wild-type form of FLNa but not the FLNa-
S2152A mutant was detected by the antibody. Notice that only the
long form of FLNa–GFP that contained the phosphorylation site
was recognized by the antibody (Fig.7A, see arrows). Treatment
with CCL2 induced a small but significant increase in FLNa
phosphorylation, 5 and 15 min after CCL2 stimulation (Fig. 7B),
which paralleled the activation of ERK by CCL2 (Fig. S4A–C).
CCL2 did not induce any increase in phosphorylation of the FLNa-
S2152A mutant that had been expressed in shFLNa HEK293 cells
(Fig. 7A, lower panel). Different kinases have been implicated in the
phosphorylation of FLNa, including several isoforms of PKC
and PKA, which are also downstream effectors of GPCR
signaling. Treatment with different protein kinase inhibitors
targeting PKCs [GF10903, Gö6976 and bisindolylmaleimide II]
(Fig. 7C–E) consistently produced a significant reduction of FLNa
phosphorylation at S2152 upon CCL2 treatment. The reduction of
phosphorylation of FLNa at S2152 in CCL2-stimulated cells upon
treatment with GF10903 was dose dependent (Fig. 7D). In contrast,
no inhibition of FLNa phosphorylation at S2152 was observed in
the presence of the PKA inhibitor H-89, even at relatively high
doses. β2AR stimulation also led to FLNa phosphorylation on
S2152 after 5 and 15 min of isoproterenol treatment (Fig. 7F,G).
Interestingly, however, phosphorylation of FLNa at S2152 induced
by β2AR was not reduced in the presence of GF10903 but on the
contrary, it was reduced in the presence of H-89. Again,
isoproterenol stimulation did not result in any phosphorylation of
the FLNa-S2152A mutant (Fig. 7F). Therefore, we can conclude
that both receptors, CCR2B and β2AR, can induce phosphorylation
of FLNa at S2152 upon ligand stimulation, most probably through
different downstream pathways.
DISCUSSION
Ourwork demonstrates a very specific role of FLNa in promoting the
recycling of CCR2B from sorting endosomes to the plasma
membrane. We showed that FLNa and internalized CCR2B
colocalized in dynamic actin- and coronin2-enriched endosomal
subdomains, which are known to concentrate cargo for the
Rab4A- and retromer-dependent pathway to the plasma membrane
(Puthenveedu et al., 2010; Temkin et al., 2011), which is also used
by other GPCRs like β2AR and AVPR2 (V2R). Interestingly, even
though filamins have a prominent role as actin cross-linkers, we also
Fig. 4. FLNa and CCR2B colocalized in actin- and coronin2-enriched
microdomains. (A) Micrographs from FLNa–GFP-expressing HEK293 cells
that had been scanned with a high-resolution STED microscope, showing the
filament pattern at the top and vesicular structures in the sagittal plane
(bottom). Arrowheads show FLNa in vesicular structures. (B) Live confocal
images of coronin2–GFP- and FLNa–DsRed-expressing HeLa cells. Images
were taken as described in Fig. 1A. Arrows show colocalization of FLNa and
coronin2. (C) Time-lapse series from a representative Rab4A–Cherry-labeled
endosome with FLNa–GFP and Flag–CCR2B in transfected HeLa cells that
had been prelabeled with anti-Flag and Alexa-Fluor-647-conjugated anti-
mouse antibodies, treated as in Fig. 1A. (D) Confocal images of live Flag–
CCR2B-expressing HeLa cells that also expressed FLNa–GFP or other cell
markers (actin–RFP, Rab4A–Cherry, Rab5A–Cherry or Rab11A–Cherry).
Cells were treated and imaged as in C for 30 min at 37°C. Arrowheads indicate
FLNa in endosome microdomains. The movies from which images in D were
taken are inMovies 2–4. (E) Confocal micrographs of HEK293 cells expressing
HA–β2AR (HA–B2AR) and FLNa–GFP that had been surface labeled with
anti-HA and anti-rat Alexa-Fluor-568-conjugated antibodies, and treated with
10 μM isoproterenol before acquisition of images. Scale bars: 5 μm.
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found that FLNa does not seem to play a major structural role in
organizing the endosomal actin-enriched microdomains, but rather
that it functions as a cargo adaptor. We showed that FLNa depletion
does not apparently alter the size or number of the endosomal
coronin2 microdomains, nor did it affect overall retrograde traffic,
but rather it specifically prevented CCR2B and β2AR loading onto
the actin-enriched microdomains and specifically delayed their
transport back to the plasma membrane. Also consistent with this
view, the actin-binding site of FLNa that is responsible for its actin
cross-linking activity was not required to sustain efficient recycling
of CCR2B and β2AR. Based on our current observations and
previous data demonstrating that FLNa interacts with several
chemokine receptors and integrins (Liu et al., 2015), which follow
the same path to the plasmamembrane, we propose that FLNaworks
as a receptor scaffold that links cargo directly or indirectly to actin
microdomains in the sorting endosome. We found that this FLNa
function is regulated by its phosphorylation at S2152, which, in turn,
is promoted by GPCR-signaling to second messenger kinases.
In addition to a direct role of FLNa in CCR2B and β2AR
recycling, our data demonstrated that FLNa depletion greatly
reduced the long-term motility of the sorting endosomes and
increased their size. Depletion of WASH (Gomez et al., 2012), or
the Arp2/3 complex (Derivery et al., 2012), also causes early
endosome enlargement. In these conditions, endosomes present
enlarged segregated subdomains with collapsed endosomal and
lysosomal networks. They do not exhibit elongated tubulations and
are devoid of filamentous actin. Although FLNa depletion increased
the endosome size, it did not seem to alter the actin-rich endosome
domains, as the number and size of the coronin2 patches remained
the same and no collapse of endosomal networks was observed,
which suggest that role of FLNa differs from that seen inWASH and
Arp2/3 studies. Whether the endosomal phenotypes observed by
FLNa depletion are a cause or a consequence of the recycling defect,
or are unrelated, is a complex question to address in the future. Thus,
a defect in the recycling of certain cargo might prevent maturation of
endosomes and their proper attachment to microtubules for long-
range movement. Reciprocally, the enlargement of endosomes
might be caused not only by the accumulation of certain cargo
unable to exit the organelle but also by maintenance of the
endosome capacity to accept vesicles from the plasma membrane,
provided that they do not move away from the cortex. Alternatively,
or additionally, depletion of FLNamight directly alter tubulin-based
motility, or the architecture of microtubules (Lynch et al., 2011),
and as a consequence, indirectly affect endosomal motility, size and
distribution (Bayer et al., 1998) without having a dramatic effect on
the actin cytoskeleton structure (Baldassarre et al., 2009). In any
case, a general alteration of the endosome motility or distribution is
unlikely to be the primary cause of the CCR2B recycling defects
because the kinetics of Tfn transport from the endosomes to plasma
membrane appeared to be unaltered in FLNa-depleted cells
(Fig. 6C,D; Minsaas et al., 2010), as did its uptake (Muriel et al.,
2011). We favor the hypothesis that FLNa acts as a scaffold that
cooperates to load the cargo into actin-enriched domains.
Concomitantly, FLNa would be needed to maintain the
distribution and motility of endosomes by interacting with actin
and/or microtubule networks. This hypothesis agrees with our
previous results showing that upon activation, CCR2B-loaded
vesicles were present in a linear distribution with directional
movement, co-aligned with actin fibers and FLNa (Minsaas et al.,
2010; Planagumà et al., 2012). It is interesting that FLNa regulates
the linear distribution of caveolae along stress fibers (Muriel et al.,
2011) and their translocation from the plasma membrane to
perinuclear Rab11 structures.
FLNa is regulated by phosphorylation at S2152 by many protein
kinases, and this phosphorylation has a direct effect on its function
in regulating a variety of cytoskeleton-related events (Hastie et al.,
1997; Muriel et al., 2011; Travis et al., 2004; Zhang et al., 2012).
Here, we show that phosphorylation of the same residue is necessary
for efficient recycling of CCR2B and β2AR. Together with the fact
that the S2152A mutant of FLNa was not present in endosomes, our
data suggest that phosphorylation of FLNa at S2152 facilitates the
accumulation of this protein on endosomal microdomains (see
model in Fig. 7I). These results agree with previous data where
Myc-tagged FLNa-S2152A localizes with actin fibers at the cell
surface, whereas phosphorylation of FLNa directs it towards the
cytoplasm of CHP100 cells (Zhang et al., 2012). We also showed
here that CCR2B and β2AR signaling can trigger phosphorylation
of FLNa at S2152. Interestingly, our data also suggests that
phosphorylation of FLNa at S2152 by these GPCRs follows
different pathways and uses different kinases because CCR2-
Fig. 5. FLNa facilitates CCR2B loading in actin-rich subdomains.
(A) Micrographs of endosomes in shFLNa or shScr cells that expressed Flag–
CCR2B, Rab4A–Cherry and coronin2–GFP. Cells were treated as described in
Fig. 3E. Arrowheads show coronin2–GFP localization. (B) Correlation of
coronin2 with CCR2B on the endosomes shown in A (left panel). The tool ‘Plot
profile’ of a free-hand-drawn line on the endosomal membrane was used to
calculate correlations between the two signals according to the Pearson’s
correlation. Right, mean number of coronin2–GFP patches on CCR2-loaded
endosomes±s.e.m. of three independent experiments (***P<0.001; two-tailed
t-test). 20 endosomes were counted per experiment. endo, endosome. (C)
Micrographs of endosomes in shFLNa or shScr cells that expressed Flag–
β2AR, Rab4A–Cherry and coronin2–GFP. Cells were treated as described in
Fig. 3C. Arrowheads show coronin2–GFP localization. Scale bars: 5 μm.
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induced phosphorylation of FLNa at S2152 was reduced by PKC
inhibitors but not by PKA inhibitors. Reciprocally, β2AR-induced
phosphorylation relied more on a PKA-dependent pathway. The
data are consistent with the different signaling cascades ignited by
the different GPCRs, CCR2 relying mainly on Gi and Gq which lead
to PKC activation (Janjanam et al., 2015; Jiménez-Sainz et al.,
2003), and β2AR on Gs, leading to PKA activation. By contrast, it is
well established that FLNa can be phosphorylated at S2152 by
cAMP-dependent PKA (Ithychanda et al., 2015; Jay et al., 2004).
Moreover, other ligand-activated GPCRs, like angiotensin II type-1
receptor (AT1R), MAS and the α1d-adrenergic receptor, have been
shown to enhance PKA-mediated filamin phosphorylation of Ig
domains 16–24 in vitro (Tirupula et al., 2015). Whether GPCR-
induced FLNa phosphorylation at S2152 is directly mediated by
PKC cannot be confirmed at this point, but it is possible given that
different isoforms of PKC have previously been demonstrated to
phosphorylate filamin A in vitro (Tigges et al., 2003). Nevertheless,
FLNa S2152 is probably phosphorylated by other kinases since
inhibitors of PKC or PKA did not completely obliterate CCR2- or
β2AR-induced phosphorylation of FLNa at S2152, and this residue
has been shown to be phosphorylated by other kinases (Gómez-
Moutón et al., 2015). Interestingly, the residue S2152 of FLNa is
located in Ig repeat 21, which is usually hidden in the autoinhibited
conformation of FLNa (Lad et al., 2007). Filamin A needs to
undergo a conformational adjustment for the phosphorylation
on S2152 to occur (Ithychanda et al., 2015). Together with our
present data, it reinforces the concept that ligand-dependent
phosphorylation of FLNa by GPCRs becomes an important
pathway for FLNa activation by promoting the phosphorylation of
S2152. Overall, we favor the hypothesis that a signaling response
leading to activation of different second messenger protein kinases
to phosphorylate FLNa, which in turn will induce its detachment
from the actin structures at the cell cortex and facilitate its
localization in highly dynamic actin-enriched endosomal
microdomains (Fig. 7I). This mechanism probably operates for
other chemokine receptors and other GPCRs.
MATERIALS AND METHODS
Constructs and reagents
Plasmids encoding FLNa–EGFP, Flag–CCR2B (Planagumà et al., 2012),
FLNa-S2152A–DsRed and FLNa-S2152E–DsRed (Muriel et al., 2011)
have been described previously. FLNa–DsRed was a gift from David A.
Calderwood (Yale School of Medicine, New Haven, CT); FLNa-
S2152A–GFP and FLNa-S2152E–GFP were derived from
pcDNA3.1-FLNa-EGFP. Human Rab4A–YFP and human
Rab5A–GFP were provided by Peter van der Sluijs (University
Fig. 6. Recycling of GPCRs is markedly delayed in FLNa-deficient HeLa
cells. Graph showing the percentage of internalized CCR2B (A) and β2AR (B)
that was recycled back to the plasma membrane. HeLa cells expressing Flag–
CCR2B or β2AR that had been surface labeled with anti-Flag antibody and
stimulated with 20 nM CCL2 or 10 μM isoproterenol for 15 min at 37°C were
acid-washed and tracked for the times indicated. Cells were then fixed and
incubatedwith Alexa-Fluor-647-conjugated antibody exclusively, just detecting
recycled receptors at the plasma membrane. Fluorescence was quantified for
n=4 independent experiments with a minimum of eight cells for each
experiment and normalized to values at time 0. Acquired image sequences
were saved as 16-bit stacks and quantified using FiJi. Data are means±s.e.m.,
shScr versus shFLNa at 60 min in A and B (**P<0.01, ***P<0.001, two-tailed
t-test). (C,D) Flowcytometry analysis of HEK293 cells for the recycling of Alexa-
Fluor-568-conjugated Tfn (0.02 mg/ml) after 2 and 60 min pulses. Cells were
then chased for the indicated times. The percentage of transferrin recycled was
calculated as 1 minus the internal fluorescence values multiplied by 100. Data
are averaged fromat least three independent experiments and shown themean
±s.e.m. (E) Flow cytometry analysis of Flag–CCR2B recycling in shFLNa cells
that had been complemented with the following mouse shFLNa-insensitive
constructs: FLNa–DsRed, FLNa-S2152E–DsRed (SE), FLNa-S2152A–
DsRed (SA) or FLNa-ABD–DsRed (ABD). Cells that had been surface labeled
with anti-Flag antibody conjugated to Alexa-Fluor-488 were induced to
internalize receptors with 20 nMCCL2 for 15 min, acid-washed and processed
for flow cytometry analysis. Internal receptor was normalized to that at time 0
after the first stripping. The percentage of antibody recycledwas calculated as 1
minus the internal fluorescence values. The upper panel shows
immunoblotting of shFLNa cells that expressed DsRed, FLNa–DsRed, FLNa-
S2152E–DsRed, FLNa-S2152A–DsRed and FLNa-ABD–DsRed. (F) The
upper panel shows immunoblots of shFLNa cells that expressed FLNa–GFP,
FLNa-S2152E–GFP and FLNa-S2152A–GFP. The lower images show
fluorescence micrographs of CCR2-loaded endosomes of shFLNa cells
expressing FLNa-S2152E–GFP or FLNa-S2152A–GFP (treated as described
in Fig. 3D). Arrowheads indicate FLNa-positive microdomains in endosomes.
Data are means±s.e.m., shScr cells versus FLNa-expressing cells (dark blue
line versus red line) (**P<0.01; two-tailed t-test). See Fig. S3 for controls of
FLNa mutant expression by immunofluorescence.
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Medical Center Utrecht, The Netherlands). pCherry-C-hRab4A and
pCherry-C-hRab5A were derived from human (h)Rab4A–YFP and
hRab5A–GFP (previously sequenced). Actin–RFP was from
Stein O. Døskeland (Department of Biomedicine, University of
Bergen, Norway). Coronin2–GFP was kindly provided by
Manojkumar A. Puthenveedu (Carnegie Mellon University,
Pittsburgh, PA). Primary antibodies used were: M1 anti-Flag
(#F3040, Sigma; 1/1000 dilution), anti-filamin 1 (E-3; mouse sc-
17749, Santa Cruz Biotechnologies; 1/1000 dilution), anti-filamin
phosphorylated at S2152 (#4761, Cell Signaling; 1/1000 dilution),
Fig. 7. Phosphorylation of FLNa at S2152 by
CCR2 signaling. (A) Validation of the antibody
against phosphorylated FLNa (pFLNa). Upper
panels, immunoblots for FLNa phosphorylated at
S2152 (pFLNa), which were then stripped and
reprobed for total FLNa in protein extracts of shFLNa
HEK293 cells that expressed FLNa (wt) or FLNa-
S2152A (SA) under control or starving conditions
(stv). Lower panels, immunoblots against FLNa
phosphorylated at S2152, which were then stripped
and reprobed for total FLNa in protein extracts of
shFLNa HeLa cells expressing Flag–CCR2B
together with FLNa or FLNa-S2152A and stimulated
with 20 nM CCL2 for 15 min. (B) Immunoblots of
HeLa cells that expressed CCR2B were stimulated
with 20 nM CCL2 for 5 and 15 min. Lysates were
subjected to immunoblotting with antibodies against
pFLNa and phosphorylated ERK (pERK), and
reprobed with anti-FLNa and anti-ERK 1 and -ERK2
antibodies (ERK) (see Fig. S4 for CCL2-induced
pERK assays). β-tub, β-tubulin. (C) HeLa cells were
pretreated with 1 µMGF10903 (GF) or DMSO for 1 h
and stimulated with 20 nM CCL2 for 5 and 15 min.
Graphs (B,C) show the amount of pFLNa (quantified
in the linear range with an Odyssey imager)
normalized to the corresponding FLNa signal from
three different experiments, expressed as the
average fold-increase±s.e.m. of FLNA
phosphorylation relative to that at time 0 (right
panels) (*P<0.05, **P<0.01, ***P<0.001; two-tailed
t-test). (D) HeLa cells that had been transfected with
CCR2B and pretreated with increasing
concentrations of H-89 (0.1, 0.5, 5 and 20 µM) and
GF10903 (GF, 0.02, 0.1, 0.5, 1 µM) were stimulated
with 20 nM CCL2 for 15 min. (E) Cells as described
in D were pretreated with Gö6976 (2 µM) or with
bisindolylmaleimide II (BI, 2 µM) or DMSO for 1 h.
(F) HeLa cells that had been transfected with Flag–
β2AR (B2AR) and pretreated with 1 µM GF10903
and 20 µM H-89 were stimulated with 10 μM
isoproterenol (Iso) for the times indicated. (G) A
graph showing the quantification of pFLNa after
stimulation for 15 min with 10 μM isoproterenol or in
cells that had been left unstimulated. (H) shFLNa
HEK293 cells that expressed FLNa (wt) or FLNa-
S2152A (SA) and had been transfected with Flag–
CCR2B and Flag–β2AR (B2AR) were stimulated
with 20 nM CCL2 and 10 μM isoproterenol,
respectively. (I) A model of homeostatic regulation of
CCR2B recycling. Phosphorylation of S2152 of
FLNa in response to CCL2 facilitates the entry of
CCR2B into actin-positive tubules and its recycling.
Tfr, transferrin receptor; pSerine2152, FLNa
phosphorylated at S2152.
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anti-phospho ERK1/2 and anti-ERK1/2 (p44/42 MAPK 137F5
#4695; Cell Signaling; dilution 1/1000), and anti-β-tubulin
(#T6199, Sigma; 1/1000 dilution) antibodies. Alexa-Fluor-647-
(#A21245, lot#651740; #A21236, lot# 716822) and Alexa-Fluor-
488-conjugated (anti-mouse #A21202, lot #536050) secondary
antibodies were from Invitrogen (all used at 1:1000 dilution).
CF488A- and CF568-labeled M1 anti-Flag antibodies (Sigma-
Aldrich) were obtained with Mix-n-Stain™ CF™ Antibody
Labeling Kit (MX488AS100-1KT, Sigma-Aldrich) following the
manufacturer’s instructions. A mouse anti-EEA-1 antibody
(#610457, BD Transduction Laboratories) was detected by an
anti-rabbit secondary antibody after treating first the antibody with
Affinity Pure Fab Fragment Rabbit Anti-Mouse IgG (H+L)
according to the manufacturer’s instructions (#315-007-003,
Jackson ImmunoResearch). For western blot infrared analysis
(Odyssey, LI-COR), IRDye680- and IRDye800-conjugated anti-
rabbit and anti-mouse secondary antibodies were used (800CW
anti-rabbit #926-32311; 800CW anti-mouse #926-32210, lot
#C1102603 from Odyssey; anti-rabbit IRDye 680RD #926-
68073, lot# C30724-04 from Odyssey, all used at 1:20000
dilution). CCL2 and human MCP-1 were from PeproTech (Rocky
Hill, NJ); [Arg8]-vasopressin acetate salt and endothelin 1 were
purchased from Sigma-Aldrich and isoproterenol was obtained from
Calbiochem.
Cell treatments and western blotting
HeLa cells were obtained from American Type Culture Collection and
always kept under low passage number from the initial clone. HEK293
(293-EBNA) were bought from Life Technologies and cultured in the
presence of G418. All cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% (v/v) fetal bovine serum in a
humidified atmosphere under 5% CO2. Cells were regularly tested for
mycoplasma contamination. All cells were grown and transfected
utilizing FuGene® 6 (Roche) in all experiments. Cells were treated
with 20 nM of CCL2 or 10 μM isoproterenol in culture medium for 5
and 15 min prior to analysis. The following concentrations of ligands
were also used: 1 µM vasopressin and 10 nM endothelin. For protein
kinase inhibition, cells were treated with varying concentrations of
GF109203X (inhibitor of PKCα, βI, βII and γ subtypes) (ENZO Life
Sciences), H-89 (general inhibitor of protein kinase A), 2 µM Gö6976
(PKCα and PKCβ inhibitor) (Sigma-Aldrich) or 2 µM
bisindolylmaleimide II (general PKC inhibitor) (Calbiochem) for
60 min. Utilizing the MISSION shRNA human system (Sigma-
Aldrich), FLNa shRNA (shRNA) against human FLNa
(TRCN0000062528 and TRCN0000062529) was used in HeLa and
HEK293 cells. Virus production was performed as described previously
(Masià-Balagué et al., 2015). Cells were solubilized in N-dodecyl-D-
maltoside buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM
MgCl2, 1% N-D-maltoside, 10 mM NaF, 1 mM Na3VO4 and protease
inhibitors), as described previously (Masià-Balagué et al., 2015). The
same amount of protein was loaded for each condition (measured by
BioRad protein assay). Western blots were visualized and quantified by
performing infrared detection (Odyssey System) in the linear range.
Cell imaging
For live imaging, HeLa or HEK293 cells that had been transiently
transfected with FLNa–GFP, FLNa–GFP-S2152A, -S2152E, Rab4A–
Cherry, Rab5–Cherry, Rab11–Cherry, actin–RFP and/or coronin2–GFP
and Flag-tagged CCR2B receptors were plated on glass chambers and
imaged after addition of anti-Flag antibody for 15 min at 4°C followed by an
incubation with anti-mouse Alexa-Fluor-647-conjugated antibody (surface
labeled) for 15 min at 4°C before addition of ligand at 37°C. HEK293 cells
were also transfected with plasmids encoding Flag-tagged receptors: β2AR,
Etb, V2R or PAR1. HA–β2AR was transiently transfected into HEK293
cells with Flag–CCR2B. Confocal imaging was performed with a Leica
TCS SP5 (Leica Microsystems, Mannheim, Germany) by using a 63×1.3
NA oil immersion lens in a sealed chamber with 5% CO2 at 37°C. Movies
were taken between 5 and 30 min after agonist addition. Each frame
corresponds to 600 ms. For high-resolution fluorescence imaging, a STED
microscope (Leica Microsystems) was utilized on live HeLa cells that
expressed FLNa–GFP. For fixed cell imaging, HEK293 cells that had been
transiently transfected with Flag–CCR2B and plated on glass chambers
were treated with CCL2 (20 nM) for 15 or 30 min at 37°C before fixation,
and processed for immunofluorescent staining (Planagumà et al., 2012).
After fixation and permeabilization, cells were incubated with anti-Flag and
anti-EEA-1 antibodies, followed by incubation with the corresponding
Alexa-Fluor-conjugated secondary antibodies (as stated in each figure
legend).
Fluorescence recovery after photobleaching
Live-cell confocal imaging was performed on transiently transfected
Rab4A–Cherry and/or Flag–CCR2B (surface labeled) control (scrambled
shRNA) and shFLNa HEK293 cells at 37°C. Images were recorded as
16-bit sequences with a pinhole of 246 µm, giving a z-slice of 2 µm, and
acquired at 3-s intervals. A 100-mW LASOS argon laser, set to 25%
intensity, was used to photobleach a Rab4A endosome, and recovery was
monitored for 26 cycles (10 s) with reduced laser power. A 488-nm line
was used to follow the Rab4A-positive endosome and a 633-nm line was
used to bleach the entire CCR2B endosome (4 µm2). Monitoring of
receptor fluorescence recovery was done for 2.5 min. The mobile fraction
(MF) was estimated as MF=(Fi–Fb)/(F0–Fb)*100, where Fi is the final
intensity upon recovery over the period of the experiment, F0 is the
intensity before bleaching, and Fb is the intensity immediately after
bleaching. Data were analyzed for 50 endosomes under each condition
and were acquired on three different days. The background was
subtracted and corrected by measuring the fluorescence decay of a
non-bleached area in the same cell and normalized to the Rab4A signal
(Rabut and Ellenberg, 2005).
Recycling assays
Quantification of receptor recycling was performed as previously
described (Patel et al., 2011) using confocal microscopy. Cells that
expressed Flag–CCR2B or Flag–β2AR were incubated with anti-Flag
antibody at 4°C for 15 min, and endocytosis was initiated by addition of
CCL2 or isoproterenol for 15 min at 37°C. Cells were acid-washed to
eliminate traces of the antibody bound to the cell surface receptor and
allowed to recover with DMEM for various time periods, washed with
ice-cold PBS-Ca2+, fixed and incubated with Alexa-Fluor-647-
conjugated antibody without permeabilization. Fluorescence intensities
were averaged over individual cells and analyzed using the FiJi
distribution of ImageJ. In each experiment, a minimum of four
replicates were analyzed for each condition. The percentage of
antibody that was recycled to plasma membrane was calculated as 1
minus the internal fluorescence values and was normalized against
values at time 0 (post agonist) (results in Fig. 6A,B).
For the Tfn flow-cytometry-based recycling assay, HeLa cells were
incubated with Alexa-Fluor-568-labeled Tfn at 0.02 mg/ml for 2 or 60 min
at 37°C to allow internalization. At 2 min, only early endosomes are
loaded with Tfn, and the kinetics of short-loop recycling can be measured.
At 60 min, mainly recycling endosomes are loaded with Tfn and,
therefore, traffic from the recycling endosomes is mostly measured. After
acid stripping, to eliminate surface-bound fluorescent Tfn, the internalized
fraction was chased at 37°C with 2 mg/ml of unlabeled Tfn for the
indicated times. At each time point, cells were acid-washed, washed with
ice-cold PBS and immediately detached using trypsin. Fluorescence
intensity profiles of cell populations (10,000 cells per sample) were
measured using a FacsAria I SORP (Becton Dickinson, San Jose, CA).
Internal Tfn was normalized for the time 0 after the first stripping. The
percentage of Tfn recycled was calculated as 1 minus the internal
fluorescence values.
Analysis of CCR2B recycling was performed in HEK293 shFLNa cells
that had been transiently expressing mouse FLNa–DsRed to rescue the
recycling delay, and also cells expressing FLNa-ABD–DsRed, FLNa-
S152A–DsRed and FLNa-S2152E–DsRed (Fig. 6E). Conjugation of
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anti-Flag M1 antibodies with CF488 was performed following the
manufacturer′s instructions (Sigma-Aldrich). Conjugated CF488A–M1
anti-Flag antibody was incubated with cells for 15 min at 4°C prior to
addition of 20 nM CCL2 and incubation for 15 min at 37°C to allow
internalization. Then, cells were acid-washed and allowed to recycle back
the receptor to the plasma membrane for the indicated times. Cells were
again acid-washed, to exclusively eliminate the antibodies attached to the
receptors reaching the plasma membrane, and trypsinized before analysis
using a FacsAria I SORP instrument (Becton Dickinson). Green
fluorescence intensity profiles were measured only in cell populations
that expressed DsRed (5000 cells per sample). The fluorescence intensity
measured is then a reflection of internalized receptor that remained
intracellularly, which decreased with time upon chase.
Statistical analysis
Data are presented as mean values or as fold induction±s.e.m. as indicated in
each figure legend. The sum of all the individual stimulatory effects were
compared to that of the combined effects by using the unpaired t-test with
two-tailed P-values, or one-way ANOVA (Fig. 1B) or two-way ANOVA
(Fig. 1D) with GraphPad Prism. Differences were considered statistically
significant when *P<0.05, **P<0.01 and ***P<0.001.
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